All In MedTech

Device Trial Radar · NCT07835178

Post-Marketing Clinical Study of High-Pressure Cutting Balloon

A Clinical Study of the High-Pressure Cutting Balloon for Interventional Treatment of Calcified Coronary Lesions

Last checked: Nov 21, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 280 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

280

Planned (sponsor's estimate)

Start

Sep 2026

Primary completion

Dec 2028

Study completion Dec 2028

Sponsor

Lead sponsor
BrosMed Medical Co., LtdNot on our public-company list
Sponsor type
Industry
First posted
Sep 22, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed as a prospective, multicenter, 1:1 randomized controlled trial. It plans to enroll 280 patients with moderate-to-severe calcified coronary lesions who are candidates for IVUS-guided DES implantation. Subjects will be randomized in a 1:1 ratio to the experimental group (n=140) or the control group (n=140). The primary endpoint is the MSA measured by IVUS immediately after the procedure, with the purpose of verifying the safety and efficacy of the high-pressure cutting balloon in optimizing stent implantation outcomes.

Conditions

  • Coronary Artery Disease
  • Calcification

Interventions

  • High pressure cutting balloonDevice

    Lesion preparation is carried out using the cutting balloon, and following completion of preparation, all stents are deployed at nominal pressure.

  • Non-cutting balloonDevice

    Lesion preparation is carried out using the non-cutting balloon, and following completion of preparation, all stents are deployed at nominal pressure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Minimum stent area (MSA) at the site of maximum calcification immediately after stent implantationTime frame: procedure day (0 day)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.